Australia, July 21 -- Belite Bio Inc., owns the trademark (2611841) for 'BELITE BIO' till Dec. 12, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of and prevention of ophthalmic disorders; pharmaceutical preparation for the treatment of and prevention of metabolic syndromes; pharmaceutical preparations for the treatment of cancer] and 42 [Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials]
Type of Mark: Word
Date of Acceptance: Feb. 12
Registration Advertised: July 20
For further details contact PHILLIPS ORMONDE FITZPATRICK.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2611841.
Disclaimer: Curated by HT Syndication.
